In last trading session, Ikena Oncology Inc (NASDAQ:IKNA) saw 0.37 million shares changing hands with its beta currently measuring 0.34. Company’s recent per share price level of $1.32 trading at $0.0 or 0.00% at ring of the bell on the day assigns it a market valuation of $63.70M. That closing price of IKNA’s stock is at a discount of -478.79% from its 52-week high price of $7.64 and is indicating a premium of 22.73% from its 52-week low price of $1.02. Taking a look at company’s average trading volume volume of 392.84K if we extend that period to 3-months.
Ikena Oncology Inc (NASDAQ:IKNA) trade information
In the last five days IKNA remained trading in the green while hitting it’s week-highest on Friday, 05/03/24 when the stock touched $1.32 price level, adding 4.35% to its value on the day. Ikena Oncology Inc’s shares saw a change of -32.99% in year-to-date performance and have moved 1.54% in past 5-day. Ikena Oncology Inc (NASDAQ:IKNA) showed a performance of -2.94% in past 30-days.
Ikena Oncology Inc (IKNA) estimates and forecasts
Statistics highlight that Ikena Oncology Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -67.57% of value to its shares in past 6 months, showing an annual growth rate of 7.98% while that of industry is 12.80. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to fall -23.60% from the last financial year’s standing.
4 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.75M for the same. And 4 analysts are in estimates of company making revenue of 1.75M in the next quarter. Company posted 5.31M and 3.08M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -7.46% during past 5 years.
IKNA Dividends
Ikena Oncology Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
